ask="N/A"
ask_size="N/A"
average_daily_volume="162968"
bid="0.01"
bid_size="100"
book_value="-91.82"
change="+1.02"
change_from_200_day_moving_average="1.88"
change_from_50_day_moving_average="1.27"
change_from_52_week_high="-0.77"
change_From_52_week_low="3.74"
change_in_percent="+6.91%"
close="15.79"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-41.42"
ebitda="-20.24M"
eps_estimate_current_year="-2.50"
eps_estimate_next_quarter="-0.43"
eps_estimate_next_year="-1.93"
ex_dividend_date="N/A"
float_shares="8856000"
high="16.06"
high_52_weeks="16.56"
last_trade_date="1/23/2017"
last_trade_price="15.79"
last_trade_size="3765"
last_trade_time="4:00pm"
low="14.30"
low_52_weeks="12.05"
market_capitalization="356.00M"
moving_average_200_day="13.91"
moving_average_50_day="14.52"
name="Ra Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="25.50"
open="14.71"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+13.49%"
percent_change_from_50_day_moving_average="+8.73%"
percent_change_from_52_week_high="-4.65%"
percent_change_from_52_week_low="+31.03%"
previous_close="14.77"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="57.92"
revenue="5.75M"
shares_outstanding="22546000"
short_ratio="2.66"
stock_exchange="NGM"
symbol="RARX"
volume="83748"
weeks_range_52="12.05 - 16.56"
